News

To talk to an attorney call 800-200-6303

News

The law firm of Bertram & Graf is committed to providing the latest news on FDA warnings and reviews to keep you well informed on clinically important safety information and reporting serious problems with human medical products.

To inquire more information regarding your legal rights in medical malpractice, please contact us immediately by filling out and submitting the form on the right.

If you or someone you love is suffering, you may wish to speak with an attorney who has experience with the legal rights in medical malpractice. Contact us for your Free Legal Evaluation
Name		*
Home Phone		*
Work/Cell Phone		*
Address		*
City, State		*
Zip		*
E-mail Address		*
Time to call
Case Description

*indicates required information Click to review terms

Why do some safety issues arise after a drug has already been approved for marketing?
FDA is always learning new information about a drug once it has been approved for sale and is in general use. Common side effects or risks of a drug are usually clear when a drug is approved. But clinical trials, which typically study several thousand people, don't reveal all of the risks. A rare problem may only come to light after the drug is used in millions of people in the larger population. The fact that FDA commonly observes new or more frequent side effects is why the agency continues to evaluate drugs after they are approved. Post-marketing surveillance is one way to monitor a drug's safety on an ongoing basis. After a drug is approved, long-term safety studies and additional clinical trials also may be conducted and evaluated.

News

Get news from some of these FDA links.

FDA: What's new in Drugs

FDA: Public Health Notifications

FDA: Medical Devices